Yesterday it was reported that the EVP,STRAT & CORP DEVT of Conmed Corp (CNMD), Peter Shagory, exercised options to sell 3,000 CNMD shares at $39.87 a share, for a total transaction value of $233.3K.
Following Peter Shagory’s last CNMD Sell transaction on February 01, 2019, the stock climbed by 8.8%.
See today’s analyst top recommended stocks >>
Based on Conmed Corp’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $243 million and quarterly net profit of $15.65 million. In comparison, last year the company earned revenue of $223 million and had a net profit of $46.7 million. CNMD’s market cap is $2.19B and the company has a P/E ratio of 55.65. Currently, Conmed Corp has an average volume of 151.6K.
Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $86.00, reflecting a 9.5% upside.
The insider sentiment on Conmed Corp has been negative according to 23 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific.
